All AbMole products are for research use only, cannot be used for human consumption.
Evorpacept (ALX148) is a high affinity CD47-blocking fusion protein with an inactive human immunoglobulin Fc region designed to enhance the activity of other anti-neoplastic therapies, with minimal additional toxicity.
Evorpacept (ALX148) is a CD47-blocking myeloid checkpoint inhibitor. The myeloid checkpoint inhibitor evorpacept was well tolerated in combination with azacitidine (AZA) with an initial safety profile similar to that of AZA monotherapy.
| CAS Number | 2484949-51-9 |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Immunology/Inflammation Products |
|---|
| Gemtuzumab
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin. |
| Cyclosporin A-d4
Cyclosporin A-d4 |
| Mycophenolic acid-13c,d3
Mycophenolic acid-13c,d3 |
| 2-Hydroxy Fluorene
2-Hydroxy Fluorene (2-FLU) has a wide range of applications in life science related research. 2-FLU can increase the expression of psoriasis-related inflammatory factors in HaCaT cells. |
| Qingdainone
Qingdainone is a natural product that can be obtained from Qingdai. Qingdainone has the potential to study cancer and inflammation |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
